Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Citation(s) in RCA

1
(from Reference Citation Analysis)

Indexed Articles

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Journal Title Analysis
Category Analysis

Results Analysis

Year Published

Show more Refine

Article Statistics

Refine

Publication Titles

Show more Refine

Category

Show more Refine

For: Liedgens H, Henske R. Comment on: "cost-utility analysis of duloxetine in osteoarthritis: a US private payer perspective". Appl Health Econ Health Policy 2013;11:553-554. [PMID: 23918680 PMCID: PMC3824295 DOI: 10.1007/s40258-013-0048-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]

For:	Liedgens H, Henske R. Comment on: "cost-utility analysis of duloxetine in osteoarthritis: a US private payer perspective". Appl Health Econ Health Policy 2013;11:553-554. [PMID: 23918680 PMCID: PMC3824295 DOI: 10.1007/s40258-013-0048-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]

Number

Cited by Other Article(s)

Wielage RC, Bansal M, Andrews JS, Klein RW, Happich M. Authors' reply to Liedgens and Henske: "cost-utility analysis of duloxetine in osteoarthritis: a US private payer perspective". APPLIED HEALTH ECONOMICS AND HEALTH POLICY 2013;11:555-557. [PMID: 23907656 DOI: 10.1007/s40258-013-0049-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]